{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:03:08Z","timestamp":1791198188485,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"863 project of China","award":["2006AA02A111"],"award-info":[{"award-number":["2006AA02A111"]}]},{"DOI":"10.13039\/501100001809","name":"national nature science foundation of China","doi-asserted-by":"crossref","award":["NSFC C03030202"],"award-info":[{"award-number":["NSFC C03030202"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.bbrc.2012.07.098","type":"journal-article","created":{"date-parts":[[2012,7,27]],"date-time":"2012-07-27T11:24:40Z","timestamp":1343388280000},"page":"368-373","source":"Crossref","is-referenced-by-count":46,"title":["Myc induced miR-144\/451 contributes to the acquired imatinib resistance in chronic myelogenous leukemia cell K562"],"prefix":"10.1016","volume":"425","author":[{"given":"Li","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingmin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2012.07.098_b0005","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood.V88.7.2375.bloodjournal8872375","article-title":"The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype","volume":"88","author":"Melo","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2012.07.098_b0010","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nrc1567","article-title":"Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia","volume":"5","author":"Ren","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2012.07.098_b0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1158\/1078-0432.12.11.1","article-title":"U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval","volume":"11","author":"Cohen","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2012.07.098_b0020","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1182\/blood.V95.5.1758.005a41_1758_1766","article-title":"Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplification","volume":"95","author":"le Coutre","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2012.07.098_b0025","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification","volume":"293","author":"Gorre","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2012.07.098_b0030","doi-asserted-by":"crossref","first-page":"34227","DOI":"10.1074\/jbc.M402290200","article-title":"A Bcr\/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2","volume":"279","author":"Dai","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2012.07.098_b0035","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1349-7006.2009.01365.x","article-title":"Contribution of BCR-ABL-independent activation of ERK1\/2 to acquired imatinib resistance in K562 chronic myeloid leukemia cells","volume":"101","author":"Nambu","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbrc.2012.07.098_b0040","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1756-8722-4-6","article-title":"BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance","volume":"4","author":"Quentmeier","year":"2011","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbrc.2012.07.098_b0045","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.leukres.2010.01.030","article-title":"Bcr-Abl-independent mechanism of resistance to imatinib in K562 cells: Induction of cyclooxygenase-2 (COX-2) by histone deacetylases (HDACs)","volume":"34","author":"Kalle","year":"2010","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bbrc.2012.07.098_b0050","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.leukres.2007.11.007","article-title":"Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: role of COX-2 and MDR-1","volume":"32","author":"Arunasree","year":"2008","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bbrc.2012.07.098_b0055","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1038\/sj.onc.1205942","article-title":"Jak2 is involved in c-Myc induction by Bcr-Abl","volume":"21","author":"Xie","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2012.07.098_b0060","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2012.07.098_b0065","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Calin","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2012.07.098_b0070","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/carcin\/bgl185","article-title":"MicroRNAs in biological processes and carcinogenesis","volume":"28","author":"Osada","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbrc.2012.07.098_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ydbio.2006.08.028","article-title":"MicroRNAs as oncogenes and tumor suppressors","volume":"302","author":"Zhang","year":"2007","journal-title":"Dev. Biol."},{"key":"10.1016\/j.bbrc.2012.07.098_b0080","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2012.07.098_b0085","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1582-4934.2008.00386.x","article-title":"The microRNAs involved in human myeloid differentiation and myelogenous\/myeloblastic leukemia","volume":"12","author":"Wang","year":"2008","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbrc.2012.07.098_b0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1476-4598-10-41","article-title":"Expression patterns of microRNAs associated with CML phases and their disease related targets","volume":"10","author":"Machova Polakova","year":"2011","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2012.07.098_b0095","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.leukres.2011.03.029","article-title":"MicroRNA-451 in chronic myeloid leukemia: miR-451-BCR-ABL regulatory loop?","volume":"35","author":"Lopotova","year":"2011","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bbrc.2012.07.098_b0100","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1158\/1078-0432.CCR-08-1818","article-title":"MicroRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells","volume":"15","author":"Bandres","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2012.07.098_b0105","doi-asserted-by":"crossref","DOI":"10.1002\/stem.741","article-title":"Microrna-451 is Involved in the Self-Renewal, Tumorigenicity and Chemoresistance of Colorectal Cancer Stem Cells","author":"Bitarte","year":"2011","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbrc.2012.07.098_b0110","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1182\/blood-2002-06-1685","article-title":"Specific inhibition of bcr-abl gene expression by small interfering RNA","volume":"101","author":"Scherr","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2012.07.098_b0115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ng.2007.30","article-title":"Widespread microRNA repression by Myc contributes to tumorigenesis","volume":"40","author":"Chang","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2012.07.098_b0120","doi-asserted-by":"crossref","first-page":"ra19","DOI":"10.1126\/scisignal.2001556","article-title":"c-MYC suppresses BIN1 to release poly(ADP-ribose) polymerase 1: a mechanism by which cancer cells acquire cisplatin resistance","volume":"4","author":"Pyndiah","year":"2011","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbrc.2012.07.098_b0125","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1158\/1541-7786.MCR-10-0510","article-title":"C-MYC oncoprotein dictates transcriptional profiles of ATP-binding cassette transporter genes in chronic myelogenous leukemia CD34+ hematopoietic progenitor cells","volume":"9","author":"Porro","year":"2011","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbrc.2012.07.098_b0130","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s12032-010-9529-9","article-title":"Knockdown of SOD1 sensitizes the CD34+ CML cells to imatinib therapy","volume":"28","author":"Liu","year":"2011","journal-title":"Med. Oncol."},{"key":"10.1016\/j.bbrc.2012.07.098_b0135","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.leukres.2008.11.013","article-title":"SFRP1 promoter methylation is associated with persistent Philadelphia chromosome in chronic myeloid leukemia","volume":"33","author":"Pehlivan","year":"2009","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bbrc.2012.07.098_b0140","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/leu.2008.262","article-title":"Beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia","volume":"23","author":"Hu","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2012.07.098_b0145","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1093\/nar\/20.9.2257","article-title":"Determination of the DNA sequence recognized by the bHLH-zip domain of the N-Myc protein","volume":"20","author":"Alex","year":"1992","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2012.07.098_b0150","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1097-2765(02)00633-0","article-title":"Negative regulation of the mammalian UV response by Myc through association with Miz-1","volume":"10","author":"Herold","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbrc.2012.07.098_b0155","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nature01119","article-title":"Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage","volume":"419","author":"Seoane","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2012.07.098_b0160","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/35070076","article-title":"Repression of p15INK4b expression by Myc through association with Miz-1","volume":"3","author":"Staller","year":"2001","journal-title":"Nat. Cell Biol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X12014052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X12014052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T18:27:00Z","timestamp":1687631220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X12014052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0006291X12014052"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2012.07.098","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}